ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Smith & Wesson (NASDAQ:SWBI) Misses Q1 Revenue Estimates, Stock Drops 12.4%

SWBI Cover Image

American firearms manufacturer Smith & Wesson (NASDAQ: SWBI) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 11.6% year on year to $140.8 million. Its non-GAAP profit of $0.20 per share was 13% below analysts’ consensus estimates.

Is now the time to buy Smith & Wesson? Find out by accessing our full research report, it’s free.

Smith & Wesson (SWBI) Q1 CY2025 Highlights:

  • Revenue: $140.8 million vs analyst estimates of $152.4 million (11.6% year-on-year decline, 7.6% miss)
  • Adjusted EPS: $0.20 vs analyst expectations of $0.23 (13% miss)
  • Adjusted EBITDA: $24.14 million vs analyst estimates of $26.19 million (17.2% margin, 7.8% miss)
  • Operating Margin: 9.3%, down from 16% in the same quarter last year
  • Free Cash Flow Margin: 23.8%, similar to the same quarter last year
  • Market Capitalization: $461.6 million

Company Overview

With a history dating back to 1852, Smith & Wesson (NASDAQ: SWBI) is a firearms manufacturer known for its handguns and rifles.

Revenue Growth

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Over the last five years, Smith & Wesson’s demand was weak and its revenue declined by 2.2% per year. This wasn’t a great result and suggests it’s a low quality business.

Smith & Wesson Quarterly Revenue

We at StockStory place the most emphasis on long-term growth, but within consumer discretionary, a stretched historical view may miss a company riding a successful new product or trend. Smith & Wesson’s revenue over the last two years was flat, sugggesting its demand was weak but stabilized after its initial drop. Smith & Wesson Year-On-Year Revenue Growth

This quarter, Smith & Wesson missed Wall Street’s estimates and reported a rather uninspiring 11.6% year-on-year revenue decline, generating $140.8 million of revenue.

Looking ahead, sell-side analysts expect revenue to grow 4.5% over the next 12 months. While this projection indicates its newer products and services will catalyze better top-line performance, it is still below the sector average.

Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.

Operating Margin

Smith & Wesson’s operating margin has shrunk over the last 12 months and averaged 7.5% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.

Smith & Wesson Trailing 12-Month Operating Margin (GAAP)

In Q1, Smith & Wesson generated an operating margin profit margin of 9.3%, down 6.6 percentage points year on year. This contraction shows it was less efficient because its expenses increased relative to its revenue.

Earnings Per Share

We track the long-term change in earnings per share (EPS) for the same reason as long-term revenue growth. Compared to revenue, however, EPS highlights whether a company’s growth is profitable.

Sadly for Smith & Wesson, its EPS declined by 17.7% annually over the last five years, more than its revenue. This tells us the company struggled because its fixed cost base made it difficult to adjust to shrinking demand.

Smith & Wesson Trailing 12-Month EPS (Non-GAAP)

In Q1, Smith & Wesson reported EPS at $0.20, down from $0.45 in the same quarter last year. This print missed analysts’ estimates. Over the next 12 months, Wall Street expects Smith & Wesson to perform poorly. Analysts forecast its full-year EPS of $0.31 will hit $0.45.

Key Takeaways from Smith & Wesson’s Q1 Results

We struggled to find many positives in these results as its revenue, EPS, and EBITDA fell short of Wall Street’s estimates. Overall, this quarter could have been better. The stock traded down 12.4% to $9.54 immediately following the results.

The latest quarter from Smith & Wesson’s wasn’t that good. One earnings report doesn’t define a company’s quality, though, so let’s explore whether the stock is a buy at the current price. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here, it’s free.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.